<DOC>
	<DOCNO>NCT02123017</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety bisacodyl combine escalate dos lactulose use preparation colonoscopy .</brief_summary>
	<brief_title>Efficacy Safety Bisacodyl Lactulose Preparation Colonoscopy</brief_title>
	<detailed_description />
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Bisacodyl</mesh_term>
	<criteria>Patients require bowel evacuation colonoscopy . Patients galactosemia ( galactosesensitive diet ) . Patients know hypersensitive component lactulose oral solution . Patients know abnormality screen vital sign assessment , Investigator 's judgment , may pose significant risk include pertain dehydration electrolyte shift . Patients history impaired renal function . Patients current recent history hypotension , define Investigator . Patients history long QT syndrome . Patients history fail bowel preparation . Patients severe constipation , define patient take daily prescription overthecounter laxative . Patients possible bowel obstruction , gastric retention , bowel perforation , toxic colitis , toxic megacolon , ileus previous colonic surgery ( except hemorrhoidectomy polypectomy ) . Patients lactulose therapy receive treatment chronic constipation . Be pregnant nursing . Patients expect require electrocautery argon plasma coagulation . Patients le 18 year age . Inability understand requirement study unwilling provide write informed consent ( evidenced signature inform consent document approve Institutional Review Board [ IRB ] ) agree abide study restriction . Be otherwise unsuitable study , opinion Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Bowel Evacuation</keyword>
	<keyword>Colonoscopy Preparation</keyword>
</DOC>